Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

Pre-treatment and acquired HIV drug resistance in Hunan: a cross-sectional analysis of a growing challenge.

BMC infectious diseases - 23 Oct 2025

Long Shujing, Yao Run, Tang Yumei, Yu Chengcheng, Tang Wei, Cao Jing, Huang Yaxiong, Lu Xinlan, Li Sai, Liu Rangjiao, Dai Lizhong, Huang Yan, Zheng Fang

Abstract excerpt

BACKGROUND: HIV Drug Resistance (HIVDR) is a key consideration when determining ART regimens. In recent years, Pre-treatment Drug Resistance (PDR) and Acquired Drug Resistance (ADR) have been changing rapidly. We studied the latest PDR and ADR cases in Hunan Province, China. METHOD: The study included People Living With HIV (PLWH) from a hospital in Hunan Province (May 2021–August 2023). Baseline characterisation...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Anti-HIV Agents
Share to China

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics

Share to Cross-Sectional Studies

Share to Drug Resistance, Viral

Share to Genotype

Share to HIV Infections

Share to pol Gene Products, Human Immunodeficiency Virus

Source

Open in PubMed Open full text

Identifiers

PMID: 41131459
DOI: 10.1186/s12879-025-11656-1
PMCID: PMC12548242

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 5 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

Pre-treatment and acquired HIV drug resistance in Hunan: a cross-sectional analysis of a growing challenge.PMID 41131459Read ↗

Prevalence of acquired drug resistance mutations in antiretroviral- experiencing subjects from 2012 to 2017 in Hunan Province of central South China.Semantic proximity Read ↗

Characterization of Pretreatment Drug Resistance among people living with HIV from 2018 to 2022 in Guangzhou, ChinaSemantic proximity Read ↗

Survey of Pretreatment HIV Drug Resistance and Genetic Transmission Network Analysis Among HIV Patients in a High Drug-Use Area of Southwest China.Semantic proximity Read ↗

Transmitted Drug Resistance Among People Living With HIV-1 in Henan Province, China, 2025Semantic proximity Read ↗

Pretreatment drug resistance among people living with HIV from 2018 to 2022 in Guangzhou, China.Semantic proximity Read ↗

Exploring disparities in HIV-1 pretreatment and acquired drug resistance in China from 2003 to 2022.Semantic proximity Read ↗

Increased prevalence of pretreatment drug resistance mutations in treatment-naïve people living with HIV-1 in Henan Province, China (2022/23).Semantic proximity Read ↗

Transmitted HIV-1 Drug Resistance Among Newly Diagnosed Individuals in 31 Provincial-Level Administrative Divisions in China in 2023: A Cross-sectional Survey.Semantic proximity Read ↗

Pretreatment HIV Drug Resistance and the Molecular Transmission Network Among HIV-Positive Individuals in China in 2022: Multicenter Observational StudySemantic proximity Read ↗

Characterization of HIV-1 subtypes and drug resistance mutations in Henan Province, China (2017-2019).Semantic proximity Read ↗

Trends and Patterns of HIV Transmitted Drug Resistance in China From 2018 to 2023.Semantic proximity Read ↗

Prevalence of Primary Drug Resistance Among Newly Diagnosed HIV-1-Infected Individuals in Hunan Province, China.Semantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.